Alert Burden When Monitoring Patients at Home

Active, not recruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

December 1, 2025

Conditions
Continuous MonitoringVital Signs MonitoringHospital at HomeRemote Monitoring
Interventions
DEVICE

Continuous vital sign monitoring

Continuous monitoring of vital signs performed using up to three CE- and FDA approved devices measuring heart rate, respiratory rate, systolic- and diastolic blood pressure, and SpO2. Data is transmitted to a CE-approved smartphone application that generates alerts in response to deviations based on predefined thresholds for duration and severity.

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT07096648 - Alert Burden When Monitoring Patients at Home | Biotech Hunter | Biotech Hunter